From the Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, Massachusetts.
Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial Veterans Affairs Hospital, Bedford, Massachusetts.
Pediatr Infect Dis J. 2019 Mar;38(3):271-274. doi: 10.1097/INF.0000000000002117.
To examine whether inappropriate antibiotic treatment for an initial bout of acute bronchitis in childhood affects patterns of future healthcare utilization and antibiotic prescribing.
We conducted a retrospective analysis of children with at least 1 acute bronchitis episode, defined as the 14-day period after an acute bronchitis visit, born in 2008 and followed through 2015 in a nationally representative commercial claims database. We predicted the likelihood of returning for a subsequent acute bronchitis episode, and being prescribed an antibiotic as part of that episode, as a function of whether or not the child was prescribed an antibiotic as part of the first acute bronchitis episode controlling for patient, provider and practice characteristics.
Children prescribed an antibiotic as part of their initial acute bronchitis episode were more likely both to have a subsequent acute bronchitis episode (hazard ratio = 1.23; 95% confidence interval: 1.17-1.30) and to be prescribed an antibiotic as part of that second episode (hazard ratio = 2.13; 95% confidence interval: 1.99-2.28) compared with children who were not prescribed as part of their first episode. Children diagnosed with asthma were more likely to experience a second visit for acute bronchitis, but less likely to receive an antibiotic as part of that second episode.
Inappropriate antibiotic prescribing for a child's initial acute bronchitis episode of care predicted likelihood of subsequent acute bronchitis episodes and antibiotic prescriptions. Providers should consider the downstream effect of inappropriate antibiotic prescribing for acute bronchitis in childhood.
为了研究儿童初次急性支气管炎期间接受不适当的抗生素治疗是否会影响未来的医疗保健利用和抗生素处方模式。
我们对至少有 1 次急性支气管炎发作(定义为急性支气管炎就诊后 14 天)的儿童进行了回顾性分析,这些儿童于 2008 年出生,并在全国代表性的商业索赔数据库中随访至 2015 年。我们预测了患儿再次因急性支气管炎发作而就诊的可能性,以及作为首次急性支气管炎发作的一部分而被处方抗生素的可能性,这取决于患儿是否在首次急性支气管炎发作期间接受了抗生素治疗,同时控制了患者、医生和实践特征。
在初次急性支气管炎发作期间接受抗生素治疗的儿童,随后发生急性支气管炎发作的可能性更高(风险比=1.23;95%置信区间:1.17-1.30),并且在第二次发作时接受抗生素治疗的可能性也更高(风险比=2.13;95%置信区间:1.99-2.28),而在初次发作期间未接受抗生素治疗的儿童则较低。被诊断为哮喘的儿童更有可能再次因急性支气管炎就诊,但在第二次发作时接受抗生素治疗的可能性较小。
儿童初次急性支气管炎治疗期间接受不适当的抗生素治疗,可预测随后发生急性支气管炎发作和抗生素处方的可能性。医生应该考虑儿童急性支气管炎治疗中不适当使用抗生素的下游影响。